Evidence map›Paper›PMID 26893784›Full record

ArticleOncology letters2016

Multiple malignant inflammatory myofibroblastic tumors of the jejunum: A case report and literature review.

Audrius Dulskas, Aurimas Klivickas, Alfredas Kilius, Narimantas E Samalavicius, Romualdas Sumauskas, Rytis Markelis

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Audrius DulskasNational Cancer Institute, Vilnius 08406, Lithuania.
Aurimas KlivickasNational Cancer Institute, Vilnius 08406, Lithuania.
Alfredas KiliusNational Cancer Institute, Vilnius 08406, Lithuania.
Narimantas E SamalaviciusNational Cancer Institute, Vilnius 08406, Lithuania; Centre of Oncosurgery, National Cancer Institute, Clinic of Internal, Family Medicine and Oncology, Faculty of Medicine, Vilnius 08406, Lithuania.
Romualdas SumauskasDepartment of Neurosurgery, Republican Vilnius University Hospital, Vilnius 04130, Lithuania.
Rytis MarkelisDepartment of Surgery, Hospital of Oncology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas 45434, Lithuania.
National Cancer Institute · LTHospital of Lithuanian University of Health Sciences Kaunas Clinics · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory myofibroblastic tumors (IMTs) are rare neoplastic lesions with a tendency for locally aggressive behavior and recurrence. IMTs most frequently occur in the soft tissues of children and young adults, with the lungs being the most commonly affected site; however, it has been recognized that any anatomical location may be involved. IMT in the jejunum is extremely rare, with only one case previously reported in the literature. The current study describes the case of a 42-year-old woman presenting with intermittent abdominal pain and small bowel intussusception that was identified during a laparotomy. Surgical resection of the jejunum, revealing 3 exophytic tumors, provided specimens for analysis. Following histological examination, a diagnosis of IMT was made. A review of the literature regarding this rare disease is also presented to emphasize the risk of local recurrence and the importance of adequate long-term follow-up.

Indexed as

adultsinflammatory myofibroblastic tumorintussusceptionjejunumsmall bowel resection

Identifiers

PMID26893784
PMCPMC4734257
OpenAlexW2239354373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.